insulin - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
ACTRAPID PENFILL human insulin (rys) 100IU/mL injection multidose cartridge AUST R: 169623 Active ingredients: insulin Dosage form: Injection, solution Sponsor: Novo Nordisk Pharmaceuticals Pty Ltd Phone: 1800 668 626	Deletion from market: 31 Dec 2026	Shortage status: To be discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability Management action: An alternative presentation is available.
HUMULIN 30/70 biosynthetic human 30% neutral 70% isophane insulin 100IU/mL injection 10mL vial AUST R: 39656 Active ingredients: insulin Dosage form: Injection, suspension Sponsor: Eli Lilly Australia Pty Ltd Phone: 1800 454 559	Deletion from market: 31 Aug 2026	Shortage status: To be discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability Management action: Alternative presentations available. Patients are advised to consult their healthcare professional to discuss alternative treatment options.
HUMULIN NPH human insulin 100IU/mL injection vial AUST R: 14634 Active ingredients: insulin Dosage form: Injection, suspension Sponsor: Eli Lilly Australia Pty Ltd Phone: 1800 454 559	Deletion from market: 31 Aug 2026	Shortage status: To be discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability Management action: Alternative presentations available. Patients are advised to consult their healthcare professional to discuss alternative treatment options.
HUMULIN R insulin 100IU/mL injection vial AUST R: 14635 Active ingredients: insulin Dosage form: Injection, solution Sponsor: Eli Lilly Australia Pty Ltd Phone: 1800 454 559	Deletion from market: 31 Aug 2026	Shortage status: To be discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability Management action: Alternative presentations available. Patients are advised to consult their healthcare professional to discuss alternative treatment options.
PROTAPHANE INNOLET human insulin (rys) 100IU/mL injection multidose cartridge AUST R: 169633 Active ingredients: insulin Dosage form: Injection, suspension Sponsor: Novo Nordisk Pharmaceuticals Pty Ltd Phone: 1800 668 626	Deletion from market: 01 Feb 2025	Shortage status: Discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability Management action: An alternative presentation is available.
PROTAPHANE PENFILL human insulin (rys) 100IU/mL injection multidose cartridge AUST R: 169635 Active ingredients: insulin Dosage form: Injection, suspension Sponsor: Novo Nordisk Pharmaceuticals Pty Ltd Phone: 1800 668 626	Deletion from market: 31 Dec 2026	Shortage status: To be discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability Management action: An alternative presentation is available.